Practicality of Prophylactic Aflibercept to Reduce Diabetic Retinopathy Progression
- PMID: 33784736
- DOI: 10.1001/jamaophthalmol.2021.0624
Practicality of Prophylactic Aflibercept to Reduce Diabetic Retinopathy Progression
Comment on
-
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.JAMA Ophthalmol. 2021 Jul 1;139(7):701-712. doi: 10.1001/jamaophthalmol.2021.0606. JAMA Ophthalmol. 2021. PMID: 33784735 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
